 |
[1] Deng HF,et al.186Re-hedtmp: a new potential therapy of bone tumor .J Nuclear Medicine, 2003,44(5):412
[2] Deng HF,Lin Li,Tan TC,et al.153Sm-Edtmp therapeutic huge bone tumors.J Nuclear Medicine, 2003,44(5):306
[3] Deng HF,Zhang XY,Tang TC.Treatment of metastatic bone pain with strontium-89.J Nuclear Medicine, 2003,44(5)
[4] Lin Li , Liang ZL,Deng HF, et al.Samarium-153-EDTMP bone uptake rate and its relation to therapeutic effect.Chinese Medical Journal, 2002,115(7)
[5] Lin Li , Deng HF,Liang ZL,et al.The meseurement of 153Sm-EDTMP bone uptake value by whole-body scintigraphy and its application in individualized treatment dosimetry of bone metastasis.核科學(xué)與技術(shù), 2000,-4
[6] Lin Li , Liang ZL, Deng HF,,et al.153SM-EDTMP therapy dosimetry by wholebody scintigraphy.The J of Nuclear Medicine, 2000,41(5S)
[7] 雷勇,馬麗莉,牛衛(wèi)中,楊玉青,鄧侯富.新型主放射性骨治療劑117Snm-TTHMP生物學(xué)性能的研究.中華核醫(yī)學(xué)雜志jfsoft.net.cn, 2004,23(6)溫廣華,鄧侯富.18F-FDG PET顯像在大腸癌診治中的應(yīng)用.中國(guó)普外基礎(chǔ)與臨床雜志, 2004,11(2)
[8] 馬麗莉,李云春,鄧侯富.碘標(biāo)記表皮生長(zhǎng)因子的代謝特性.同位素, 2002,15(3)
[9] 馬麗莉,雷勇,鄧侯富.肺癌患者18FDG-PET的臨床意義.同位素, 2002,15(1)
[10] 胡疏,鄧侯富,蔣樹(shù)斌.153Sm-羥乙基乙二胺三甲撐膦酸（HEDTMP)的動(dòng)物實(shí)驗(yàn)研究.中華核醫(yī)學(xué)雜志, 2002,22(6)
[11] 鄧侯富,譚天秩.153Sm-EDTMP治療骨轉(zhuǎn)移癌應(yīng)注意的幾個(gè)問(wèn)題.中華核醫(yī)學(xué)雜志, 2001,21(3)
[12] 李林,梁正路,鄧侯富.153Sm-EDTMP顯像測(cè)定骨攝取率在個(gè)體化治療劑量計(jì)算中的應(yīng)用.中華核醫(yī)學(xué)雜志, 2001,21(4)
[13] 李林,鄧侯富,譚天秩.親腫瘤顯像劑99Tcm(V)-DMSA顯像對(duì)153Sm-EDTMP治療骨轉(zhuǎn)移癌的療效評(píng)價(jià).同位素, 2000,13(1)
[14] 鄧侯富,譚天秩,張錫英.153Sm-EDTMP治療肺癌骨轉(zhuǎn)移.中國(guó)肺癌雜志, 2000,3(3)
[15] 胡疏,鄧侯富.國(guó)外放射性核素89Sr治療骨轉(zhuǎn)移癌的進(jìn)展.同位素, 2000,13(2)
聯(lián)系方式:
電話： 028-8522697 郵箱:deng1hf@163.com |
